are there natural glp-1 agonists America's Poison Centers GLP-1 Natural Alternatives: Supporting Metabolic
Description
P =0.01) and hospitalizations (HR, 0.88
They were all large-scale trials involving 3,000 to 18,000 patients who were either at high risk of or having established ASCVD, with trial durations ranging from 15 to 60 months
Regarding safety, the most common adverse events associated with Retatrutide were gastrointestinal-related
May provide cardiovascular benefits for some patients
